TUBERCULOSIS PLEURAL EFFUSION - MANAGEMENT



Similar documents
Table. Positive Purified Protein Derivative Results (Pediatrics In Review Apr 2008)

Clinical description 2 Laboratory test for diagnosis 3. Incubation period 4 Mode of transmission 4 Period of communicability 4

THE NATURAL HISTORY OF PULMONARY TUBERCULOSIS

Pictorial Review of Tuberculosis involving the Pleura.

Tuberculosis. Subject. Goal/Objective. Instructions. Rationale. Operations Directorate, Health Branch Immigration Medical Examination Instructions

Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND

Appendix B: Provincial Case Definitions for Reportable Diseases

2011 NTP Paediatric guidelines update- final draft

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart

Anatomy Pleura Visceral Layer outer surface of lung Separates lobes of lung from each other Parietal Layer inner surface chest wall Pleural linings Co

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours

Clinical Scenarios In Childhood TB. Josefina Cadorna Carlos M.D., FPPS, FPIDSP, FSMID Associate Professor of Pediatrics U E R M M M C

Therapy of pleural effusions Modern techniques

Guidelines for TB Blood Testing. Minnesota Department of Health TB Prevention and Control Program June 2011

Key Performance Indicator (KPI) Matrix for Performance Measurement Framework Integrated TB Services (ITBS)

TUBERCULOSIS SCREENING AND TREATMENT IN PREGNANCY. Stephanie N. Lin MD 2/12/2016

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

Tuberculosis Exposure Control Plan for Low Risk Dental Offices

Recurrent or Persistent Pneumonia

Key Performance Indicator (KPI) Matrix for Performance Measurement Framework

LEARNING OUTCOMES. Identify children at risk of developing TB disease. Correctly manage and refer children suspected of TB. Manage child contacts

Assisted Living - TB Risk Assessment

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

Understanding Pleural Mesothelioma

MANAGEMENT OF TUBERCULOSIS

Malignant Mesothelioma

TB Prevention, Diagnosis and Treatment. Accelerating advocacy on TB/HIV 15th July, Vienna

Malignant Mesothelioma

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

Neoplasms of the LUNG and PLEURA

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

Malignant Lymphomas and Plasma Cell Myeloma

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University

How To Diagnose And Treat A Tumour In An Effusion

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

Transmission & Pathogenesis of Tuberculosis

SARCOIDOSIS. Signs and symptoms associated with specific organ involvement can include the following:

Linfoma maligno pulmonar tratado com Nerium oleander. CASE REPORT

Thymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.

Pleural Diseases. Pleural Diseases. Director, Pulmonary Vascular Program Respiratory Institute Cleveland Clinic FACP, FRCP(C), FCCP, FCCM, FAHA

Paediatrica Indonesiana. Limitations of the Indonesian Pediatric Tuberculosis Scoring System in the context of child contact investigation

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC

Case Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement during Initial Diagnosis

Management of Tuberculosis (TB)

Mesothelioma: Questions and Answers

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

GUIDELINES FOR TUBERCULOSIS PREVENTIVE THERAPY AMONG HIV INFECTED INDIVIDUALS IN SOUTH AFRICA

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003

GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN

Recent Advances in The Treatment of Mycobacterium Tuberculosis

FREQUENTLY ASKED QUESTIONS about asbestos related diseases

TB CARE EARLY DETECTION AND PREVENTION OF TUBERCULOSIS (TB) IN CHILDREN. Risk factors in children acquiring TB:

YOUR LUNG CANCER PATHOLOGY REPORT

TB Diagnostics: looking back and looking forward

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention

Cervical lymphadenopathy

WHAT S WRONG WITH MY GALL BLADDER? GALL BLADDER POLYPS

Cystic Lung Diseases. Melissa Price Gillian Lieberman, MD Advanced Radiology Clerkship Beth Israel Deaconess Medical Center November, 2008

Hawaii Administrative Rules. Title 11. Department of Health. Chapter 164. Tuberculosis

International Journal of Case Reports in Medicine

Tuberculosis: FAQs. What is the difference between latent TB infection and TB disease?

Pulmonary interstitium. Interstitial Lung Disease. Interstitial lung disease. Interstitial lung disease. Causes.

What is Mesothelioma?

CT findings in Differential Diagnosis between Tuberculous Pleurisy and Malignant Effusion

Pediatric Latent TB Diagnosis and Treatment

IMA Knowledge June, 2015

3. Blood and blood products such as serum, plasma, and other blood components.

Pregnancy and Tuberculosis. Information for clinicians

CNS TOXOPLASMOSIS. Dr Farida Amod NeuroAids Meeting Blantyre, Malawi June 2004

MEDICAL REPORT MEDICAL HISTORY QUESTIONS

Perils and Pitfalls in Clinical Trials of Diagnostic Tests for Tuberculosis. Richard O Brien, MD Foundation for Innovative New Diagnostics Geneva

Tuberculosis in Children and Adolescents

Nurse Aide Training Program Application Checklist

D. FREQUENTLY ASKED QUESTIONS

How To Diagnose And Treat A Pleural Effusion

Rheumatology Labs for Primary Care Providers. Robert Monger, M.D., F.A.C.P Frontiers in Medicine

بسم هللا الرحمن الرحيم

TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG

PROBLEM-ORIENTED MEDICAL RECORD (POMR)

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection

MIOSHA s Tuberculosis Guidelines For Worker Protection from Mycobacterium (Occupational Health Program Directive No. 96-9)

San Francisco Guidelines on the Use of QuantiFERON-TB Gold (In Tube Method) for the Diagnosis of Latent TB Infection

CERVICAL MEDIASTINOSCOPY WITH BIOPSY

WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED?

Side effect of drugs, such as amphetamines, tranquilizers, bulk-type laxatives containing psyllium and certain antibiotics

Transcription:

TUBERCULOSIS PLEURAL EFFUSION - MANAGEMENT Introduction : ETB 15-20% Pleural effusion 20% in non HIV Under reporting because of AFB negative in fluid In HIV patients: EPTB 20% PTB + EPTB 50% Pleural Effusion 20% It is more common in young populations. Now tendency to affect aged patients. (IndianJMedical Res )

PATHOGENESIS Typically 4-7 months following initial infection with TB. Rupture of small subpleural focus Delayed hypersensitivity reaction Possibility the intense inflammation obstructs the lymphatic pores in the parietal pleura which causes accumulation of protein in pleural cavity.

CLINICAL MANIFESTATION Most commonly manifests as an acute illness Cough 70%, usually non productive Chest pain 75% Usually unilateral Bil Occurs in 10%

NATURAL HISTORY OF UNTREATED EFFUSION 90% usually subside spontaneously Effusion usually resolve and all other symptoms disappear within 2-4 months Follow up over time 40-60% develop tuberculosis Size of original effusion and the presence or absence of small radiologic residual pleural disease do not correlate with subsequent tuberculosis Residual pleural thickening common sequelae ~ 50%.

DIAGNOSIS Diagnosis depends on the demonstration of tubercle bacilli In sputum Pleural fluid Pleural biopsy specimen Granuloma in pleura The diagnosis can also be established with reasonable certaintly by ADA

TUBERCULIN TEST Positive in 60-75% patients, many of negative patients will become tuberculin positive in 6-8 week Negative tuberculin HIV patients & malnutrition There may sequestration of PPD reactive lymphocytes in the pleural space. A circulating adherent cell suppresses the sensitized T- lymphocytes

Sputum Examination Even in absence of underlying infiltrate Sputum AFB & culture 55%

RADIOLOGY Parenchymal infiltrates 20% The classic patterns of primary tuberculosis in the form of non cavitary, lower lobe parenchymal infiltrates. CT Scan 40% parenchyma involvement Encysted effusion usually occurs during ATT treatment Most often encystment occurs in the costoparietal regions ( Post aspects)

PLEURAL FLUID ANALYSIS Often protein > 5.0 gm/ dl Usually more than 50% lymphocytes If symptoms less than 2 weeks then pleural fluid may reveal poly. > 10% usually excludes the Eosinophil diagnosis of tuberculosis pleuritis. Mesothelial cells < 3%. HIV infected patients with tuberculosis pleuritis may have significant number of mesothelial cells in the pleural fluids.

ADA Enzyme that catalyzes the conversion of adenosinie to inosine. 1978 Pirus et al ADA-1 All cells ADA -2 Only in monocytes Majority of ADA in tuberculosis pleural fluid is ADA -2 Higher the pleural fluid ADA level, the more likely patient is to have tuberculosis.

ADA (contd.) Level of cut-off value High Specificity 83% Sensitivity 77-100% L: N > 0.75 Specificity High ADA empyema - Rheumatoid arthritis But do not have pleural fluid lymphocytosis Cut off value < 40 40-60

ADA ( contd.) Although the use of a ratio of the ADA -1 to ADA -2 less than 0: 42 will slightly increase the sensitivity and specificity of ADA, the separation of ADA into its isoenzyme is not necessary. ADA level maintained at ambient temperature. It decreases with time. But addition of glycerol, sodium sulfate Stable at room temperature for 3 months.

INTERFERON GAMMA Produced by CD4 Sensitivity & specificity > 94% It retains diagnostic efficacy in HIV patients IFN - γ is more specific than ADA chiefly due to low levels of IFN in lymphoma and empyma. Expensive not used routinely.

PCR PCR is certainly not superior to either the pleural fluid ADA or interferon gamma levels Sensitivity ~ 80% Specificity is not 100% False positive may occur due to DNA contamination Nonviable organism Latent infection Reactivation due to imunosuppression caused by primary malignant involvement of pleura.

Lysozyme Released from lysozyme containing cells granulocytes, monocytes, macrophages. The value of lysozyme levels in the diagnosis of tuberculosis effusion, however, is controversial

ADA : Lysozyme, has been found to be useful in differentiating tuberculosis from empyema. A thresholds value above 3.3 has been shown to be highly specific for tuberculosis pleural effusion.

PLEURAL FLUIDS STAINS AND CULTURE In immunocompetent patients AFB smear rarely positive. In HIV patients AFB smear is positive 20% Pleural fluid culture is positive ~ 40% Use of BACTEC system with bedside inoculation provides higher yield and faster results than do conventional methods.

PLEURAL BIOPSY The demonstration of granuloma in the parietal pleura suggests TB Other common causes of granuloma fungal disease RA Sarcoidosis Acid fast stain is positive in 25%. Culture for AFB positive 60%. Combination of three test. Positive in 91%.

Standard recommendation for biopsy If ADA > 70 L:N > 0.75 No biopsy If ADA 40-70 : L:N > 0.75 Presumptive diagnosis of tuberculosis Biopsy if clinical picture is not supportive of tuberculosis ADA < 40- Clinical picture suggestive of tuberculosis Pleural biopsy

USG guided ( Tru cut ) biopsy of pleura Involvement of pleura is not uniform, so closed biopsy may miss actual site of lesions. Closed biopsy with cope or an abrams needle can obtain adequate specimen and achieve 57-80% diagnostic rate in tuberculosis pleuritis.

DISADVANTAGES Air leakage Needle breakage May not be diagnostic Abrams needle wide bore, needs skin incision Nonspecific changes upto as high as 68% have been reported in the closed biopsy.

USG GUIDED TRU CUT BIOPSY Advantages It can localize the minimal or loculated effusion it can demonstrate focal pleural thickening sensitivity for pleural tuberclosis 86%

TREATMENTS Goals To prevent the subsequent development of active tuberculsosis To relieve symptoms to prevent development of a fibrothorax

ATT Average patient becomes afebrile without 2 week Complete resorption of fluid 6-12 weeks The incidence of pleural thickening at 6-12 months -50%

CORTICOSTEROIDS No role of systemic steroids If more than mildly symptomatic A therapeutic thoracentesis is recommended Severe symptoms & diagnosis has been established Steroids

Surgical procedure Large pleural effusion thoracentesis, Decortication rarely necessary Tuberculosis Empyema ICTD + ATT

HIV & TUBERCULOSIS PLEURAL EFFUSION Incidence CD4 < 200-0 CD> 200 - Overall incidence - ± Duration of illness longer Chest pain less common

Systemic manifestation Fever, anemia, lymphadenopathy, organomegaly common Mantoux test often negative (40%) AFB smear in pleural fluid -25% If CD4 count < 100. 50% positive fluid AFB smear positive Significant number of mesothelial cells in their pleural fluid Biopsy Granuloma on pleural biopsy are less well formed In pleural fluid,the level of albumin are relatively low The level of ADA in patients without AIDS are comparable.

THANK YOU